Skip to main content
. 2018 Jan 17;5(2):354–363. doi: 10.1002/ehf2.12249

Figure 1.

Figure 1

Flow chart of participants in the randomized controlled trial. Five hundred four patients were enrolled at 17 centres and assessed for eligibility. Of those enrolled, nine were excluded from randomization for screening failure. Four hundred ninety‐five patients were randomized, of which 333 were allocated to the maximal‐tolerated‐dose group and 162 patients were allocated to the low‐dose group.